A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction
NCT: NCT07592533 · RECRUITING
Brief Summary
This is a device study (while the device has been patented and cleared by the FDA, the indication of the use for Erectile Dysfunction has been yet approve). EXSTACY is a study to collect information on which patients who have trouble getting or keeping an erection rigid enough for sex (sometimes known as Erectile Dysfunction or ED) benefit from light intensity shockwave therapy (LI-SWT). LI-SWT is a form of energy transfer to the penis that has been shown to help some men with ED in studies over the past decade. This study will collect information about patients prior to treatment to determine what predicts a good outcome. The investigators hope that this information will help decide which patients are likely to benefit from LI-SWT and which patients should consider other treatments for ED.
Frequently Asked Questions
What is A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction?
A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction is a clinical trial registered under NCT07592533. Current status: RECRUITING.
What is the status of NCT07592533?
The current status of NCT07592533 (A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction) is: RECRUITING.
When did A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction start?
A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction started on 2024-09-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.